CB Insights
Technology Market Intelligence
Technology Market Intelligence
AVANIR Pharmaceuticals is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. The Company develops treatments for pseudobulbar affect, diabetic peripheral ...Show all
Company (Acquired)
Phone: 949-389-6700
30 Enterprise
Suite 400
Aliso Viejo, 92656
California, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Name | Firm |
|---|---|
| Login to see details | Domain Associates |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | Mar 08, 2012 | Jul 24, 2012 | Patent |
| Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | May 22, 2017 | Application | |
| Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of depression, anxiety, and neurodegenerative disorders | Feb 22, 2017 | Application | |
| Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor | Jan 27, 2017 | Application | |
| Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor | Jan 19, 2017 | Application |
